Rocket Lab Stock Falls Despite Record Q2 Revenue, Neutron Delay

Rocket Lab Corporation (RKLB) reported Q2 2026 results after the close on August 11, posting record revenue of $234M (up 62% YoY) and a blowout $2.36B backlog, yet shares fell as the Neutron first-flight window narrowed with Q4 2026 now appearing tight. The stock had rallied over 41% from its July 29 lows heading into earnings, fueled by a string of landmark government contracts totaling over $663M in new awards. The mixed reaction reflects the market pricing in near-term execution risk against a longer-term strategic story that is, by most measures, accelerating.

Key Drivers of the RKLB Stock Move

• Main Catalyst: Q2 revenue beat at $234M vs. the $231M consensus, with Q3 guidance of $250-$265M also above the $238M estimate, but EPS missed at -$0.08 vs. -$0.07 expected, and Neutron’s first launch window is visibly compressing toward year-end or beyond.
• Bull Case: Record $2.36B backlog, more than $1B in new bookings signed in Q2 and post-quarter, landmark $397M Space Force Flatellite contract, Iridium acquisition unlocking a recurring-revenue space applications vertical, and Q3 guide implying continued 10%+ sequential top-line growth.
• Bear Case: Operating cash outflow widened to -$84.1M in Q2 (from -$50.3M in Q1), Neutron’s first launch is not guaranteed in 2026 per prediction markets (14% probability), gross margins guided lower in Q3 (29-31% GAAP vs. 36.1% in Q2), and CEO/CFO/COO sold a combined ~$300M+ in stock across Q2 and into July.

RKLB is attempting to build a vertically integrated space powerhouse at considerable cost. The Iridium deal, expected to close mid-2027, would bring $870M in annual recurring revenue but also adds complexity and a large financing burden. Free cash flow will remain deeply negative through Neutron’s ramp, and management has guided that EBITDA positivity arrives “the quarter after Neutron’s first successful test flight” with cash flow breakeven 18-24 months after that. Investors must weigh an exceptional contract pipeline against a business that is still burning significant cash with no near-term path to profitability on a standalone basis.

RKLB Earnings Call Transcript Summary

Rocket Lab’s Q2 call was headlined by record revenue, an unmatched backlog, and the strategic logic behind its pending Iridium acquisition, which CEO Peter Beck described as transforming the company into a “self-licking ice cream” capable of building, launching, and operating its own satellite constellation. Three key takeaways underscored the momentum but also the risks ahead:

• Neutron is converging on the pad for Q4 2026, with all major hardware sections in final assembly or systems testing, though Beck acknowledged the window for a year-end launch is “narrowing” and focus has shifted to ensuring a high-cadence, reusable program from flight one onward.
• Iridium unlocks the third leg of the space value chain (space applications), giving Rocket Lab a 66-satellite constellation with 2.5M subscribers and $870M in annual revenue as its foundation for growth in IoT, direct-to-device, PNT, and defense.
• Cash burn remains elevated, with CFO Adam Spice noting that Neutron tail production, the Mynaric integration, and SDA program buildout all contributed to -$110.1M in non-GAAP free cash flow in Q2, with no relief expected until after Neutron’s first successful flight.

RKLB Smart Money Activity

Insider selling has been a consistent and notable feature of RKLB over the past several months. CEO Peter Beck executed three large open-market sales in early July totaling approximately $286M (~3.28M shares), reducing his position from roughly 5M shares to 1.7M shares. CFO Adam Spice sold $8.9M in May and $4.4M in March. COO Frank Klein sold over $17M across multiple transactions in the same window. While many of these trades appear to be on pre-arranged schedules (10b5-1 plans are common for executives at this price level), the scale and concentration of Beck’s July sales are notable given they occurred as the stock was already in a sharp drawdown from its YTD highs. No government/congressional trades were recorded for RKLB in the period reviewed.

RKLB Unusual Options

Options flow heading into and following earnings was exceptionally active and mixed. On August 11 (post-earnings), the most distinctive flow was a large repeated sweep in the Jun ’27 $90 Call (309 DTE), with multiple bullish at-ask sweeps totaling over $1.5M in cumulative premium paid — a notable bet on recovery well above current prices by mid-2027. On the bearish side, multiple sweeps hit the Mar ’27 $70 and $110 Puts and a Jan ’28 $80 Put sweep hit at-ask. Pre-earnings on August 10, a $588K sweep in Jan ’27 $70 Puts and a $381K sweep in Jan ’27 $60 Puts (both neutral-tagged) suggested institutional hedging ahead of the print. The overall flow picture is two-sided: long-dated call buyers are expressing conviction in a recovery, while elevated put flow reflects real near-term downside hedging.

RKLB Analyst Focus

• Upgrades / Positive Actions:
  • KeyBanc upgraded to Buy, $135 target (Jun 15)
  • KGI Securities upgraded to Buy, $107 (Jul 27)
  • Cantor Fitzgerald raised target to $122, maintains Overweight (Aug 11)
  • Citizens reiterates Market Outperform, $130 target (Aug 11)
  • Roth Capital, Craig-Hallum, Needham, Bank of America all confirmed Buy-equivalent ratings in late June with targets ranging from $115-$130

• Neutral/Hold:
  • BTIG: Hold, no target
  • Piper Sandler: Hold, $83 target (initial coverage, Jul 16)
  • KGI Securities: Initial Hold, $105 (Jun 11, before upgrade)

• Median Price Target: Based on available targets, the median sits approximately at $120-$122, implying meaningful upside from current levels near $78-$80 post-earnings.

RKLB Seasonality

Based on data since January 2021 (5-6 samples per month). August has historically been one of RKLB’s stronger months, with a 67% win rate and an average gain of +8.7% across 6 samples. The broader Q3-Q4 seasonal window (Aug through Nov) has also been favorable on average, though sample sizes are small given the stock’s listing date. February and March are historically the weakest months by a wide margin.

RKLB Relative Performance

RKLB entered Q2 as a relative outperformer, sitting at the 96th percentile vs. its sector peers in mid-May. That ranking eroded steadily through late June and collapsed sharply in mid-July following the CEO’s large share sales and broader sector weakness, reaching the 21st percentile by July 21. Following the Space Force contract wins and the pre-earnings rally, relative performance recovered to the 55th percentile by August 7, only to fall sharply again post-earnings to the 14th percentile as of August 11. The stock has gone from sector leader to sector laggard over a 90-day period, despite the fundamental business continuing to execute at a record pace.